{
    "clinical_study": {
        "@rank": "8314", 
        "arm_group": [
            {
                "arm_group_label": "People with ALS", 
                "description": "People diagnosed with early ALS (possible, probable, or probable-laboratory supported ALS according to El Escorial criteria)"
            }, 
            {
                "arm_group_label": "Other Neurological Diseases", 
                "description": "People with a diagnosis of a disease that mimics ALS"
            }, 
            {
                "arm_group_label": "Healthy Controls", 
                "description": "Healthy Volunteers that do not have ALS or another neurological disease that mimics ALS."
            }
        ], 
        "brief_summary": {
            "textblock": "This trial is studying Electrical Impedance Myography (EIM) for measuring muscle health.\n      The trial is studying people with Amyotrophic Lateral Sclerosis (ALS),  other neuromuscular\n      diseases, and healthy volunteers to see if the EIM device can measure disease in muscle\n      tissue."
        }, 
        "brief_title": "Study of Electrical Impedance Myography (EIM) in ALS", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Amyotrophic Lateral Sclerosis", 
            "Motor Neuron Disease", 
            "Charcot-Marie-Tooth Disease", 
            "Multiple Sclerosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Amyotrophic Lateral Sclerosis", 
                "Charcot-Marie-Tooth Disease", 
                "Nerve Compression Syndromes", 
                "Hereditary Sensory and Motor Neuropathy", 
                "Multiple Sclerosis", 
                "Neuromuscular Diseases", 
                "Sclerosis", 
                "Tooth Diseases", 
                "Motor Neuron Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a multicenter, 9-month study evaluating the effectiveness of electrical impedance\n      myography (EIM) as a diagnostic and disease-tracking tool.  In addition, the following will\n      be studied:\n\n        1. Determine EIM device's ability to discriminate between ALS and \"look-alike\" non-fatal,\n           motor-predominant syndromes;\n\n        2. Track EIM progression over time and determine the best summary EIM measure that could\n           serve as an endpoint in future clinical trials and individual patient care; and,\n\n        3. Determine whether EIM progression is predictive of a combined outcome of survival and\n           progression as measured by ALS Functional Rating Scale, Revised (ALSFRS-R), Hand-held\n           Dynamometry (HHD) and Vital Capacity (VC) measures."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Early ALS Inclusion Criteria:\n\n          -  Sporadic or familial ALS (as defined by revised El Escorial criteria)\n\n          -  Onset of weakness or spasticity due to ALS \u2264 24 months prior to the\n             Screening/Baseline Visit.\n\n          -  Slow vital capacity (SVC) \u226560% of predicted for gender, height, and age\n\n        Early ALS Exclusion Criteria:\n\n          -  Diagnosis of definite ALS\n\n          -  The presence of unstable psychiatric disease, cognitive impairment, or dementia that\n             would impair ability of the subject to provide informed consent, or a history of\n             active substance abuse within the prior year.\n\n        ALS Disease Mimics Inclusion Criteria:\n\n        - Diagnosis of one of the following:\n\n        a. Pure Lower Motor Neuron Disease (LMND) mimics: i. Multi-focal motor neuropathy ii.\n        Autoimmune motor neuropathy iii. Cervical or lumbosacral radiculopathies with weakness\n        involving more than one extremity or more than a single myotome if restricted to one\n        extremity.\n\n        iv. Multiple peripheral mononeuropathies with clinical weakness v. Charcot-Marie-Tooth\n        Disease b. Pure Upper Motor Neuron Disease (UMND) mimics: i. Cervical myelopathy ii.\n        Multiple sclerosis iii. Hereditary spastic paraparesis\n\n        ALS Disease Mimics Exclusion Criteria:\n\n          -  Diagnosis of possible, probable, probable-laboratory supported, or definite ALS\n\n          -  Presence of positive family history of ALS.\n\n          -  The presence of unstable psychiatric disease, cognitive impairment, or dementia that\n             would impair ability of the subject to provide informed consent, or a history of\n             active substance abuse within the prior year.\n\n        Healthy Volunteer Inclusion Criteria:\n\n        - Absence of a known neurological disorder.\n\n        Healthy Volunteer Exclusion Criteria:\n\n          -  History of ALS, myopathy, neuropathy, ALS mimic disorder or other neurodegenerative\n             disease.\n\n          -  Presence of positive family history of ALS.\n\n          -  The presence of unstable psychiatric disease, cognitive impairment, or dementia that\n             would impair ability of the subject to provide informed consent,  or a history of\n             active substance abuse within the prior year.\n\n        *Please note that this is not a complete listing on all eligibility criteria.*"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "35 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "People with ALS People diagnosed with early ALS (possible, probable, or probable-\n        laboratory supported ALS according to El Escorial criteria)\n\n        Other Neurological Diseases People with a diagnosis of a disease that mimics ALS\n\n        Healthy Controls Healthy Volunteers that do not have ALS or another neurological disease\n        that mimics ALS."
            }
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02011204", 
            "org_study_id": "2013P001505"
        }, 
        "intervention": {
            "arm_group_label": [
                "People with ALS", 
                "Other Neurological Diseases", 
                "Healthy Controls"
            ], 
            "description": "In EIM, high-frequency alternating electrical current is applied to localized areas of muscle via surface electrodes and the consequent surface voltage patterns analyzed.\nEIM is very sensitive to the compositional and structural elements of muscle. Data from both human subjects and animal disease models, including ALS, spinal muscular atrophy (SMA), and Duchenne muscular dystrophy (DMD), show that EIM may be sensitive to a variety of pathological states. It is anticipated that EIM will thus likely be able to assist in quantifying the severity of the disease affecting various muscle groups as well as in measuring changes in the disease over time.", 
            "intervention_name": "Electrical impedance myography (EIM)", 
            "intervention_type": "Device", 
            "other_name": "EIM1102 device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 10, 2014", 
        "location": [
            {
                "contact": {
                    "email": "sumaira.hussain@med.miami.edu", 
                    "last_name": "Sumaira Hussain", 
                    "phone": "305-243-8487"
                }, 
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33136"
                    }, 
                    "name": "University of Miami Miller School of Medicine"
                }, 
                "investigator": {
                    "last_name": "Michael Benatar, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "tpeng1@partners.org", 
                    "last_name": "Theodore Peng", 
                    "phone": "617-643-2522"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Massachusetts General Hospital"
                }, 
                "investigator": {
                    "last_name": "William David, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jennifer@skulpt.me", 
                    "last_name": "Jennifer Martino", 
                    "phone": "888-382-8824"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02210"
                    }, 
                    "name": "Skulpt, Inc"
                }, 
                "investigator": {
                    "last_name": "Erik Ensrud, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "perryt@upstate.edu", 
                    "last_name": "Tanya Perry", 
                    "phone": "315-464-4998"
                }, 
                "facility": {
                    "address": {
                        "city": "Syracuse", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "13210"
                    }, 
                    "name": "SUNY Upstate Medical University"
                }, 
                "investigator": {
                    "last_name": "Jeremy Shefner, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mmarandi@wakehealth.edu", 
                    "last_name": "Mozhdeh Marandi", 
                    "phone": "336-713-8577"
                }, 
                "facility": {
                    "address": {
                        "city": "Winston-Salem", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27157"
                    }, 
                    "name": "Wake Forest University Health Sciences"
                }, 
                "investigator": {
                    "last_name": "James Carress, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "3", 
        "official_title": "Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance", 
        "overall_contact": {
            "email": "cbrescia@partners.org", 
            "last_name": "Casey Brescia", 
            "phone": "617-643-7434"
        }, 
        "overall_official": {
            "affiliation": "State University of New York - Upstate Medical University", 
            "last_name": "Jeremy Shefner, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Determine EIM device's ability to discriminate between ALS and \"look-alike\" non-fatal, motor-predominant syndromes", 
            "measure": "Discrimination between Groups", 
            "safety_issue": "No", 
            "time_frame": "Duration of the Study (9 months for Group A, one visit for Groups B and C)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02011204"
        }, 
        "responsible_party": {
            "investigator_affiliation": "State University of New York - Upstate Medical University", 
            "investigator_full_name": "Jeremy Shefner", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Track EIM progression over time and determine the best summary EIM measure that could serve as an endpoint in future clinical trials and individual patient care", 
                "measure": "Tracking Progression", 
                "safety_issue": "No", 
                "time_frame": "Duration of Study, (9 months for Group A, one visit for Groups B and C)"
            }, 
            {
                "description": "Determine whether EIM progression is predictive of a combined outcome of survival and progression as measured by ALSFRS-R, HHD and VC.", 
                "measure": "Correlation with Outcome Measures", 
                "safety_issue": "No", 
                "time_frame": "Duration of Study (9 months for Group A, one visit for Groups B and C)"
            }
        ], 
        "source": "State University of New York - Upstate Medical University", 
        "sponsors": {
            "collaborator": {
                "agency": "Skulpt, Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "State University of New York - Upstate Medical University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}